Morris & Dickson partners with Mark Cuban Cost Plus Drugs
Morris & Dickson, a large independent pharmaceutical distributor, is partnering with Mark Cuban Cost Plus Drug Company and the Cost Plus Marketplace to significantly expand access to critical injectable medications nationwide, addressing key challenges for hospitals, pharmacies, clinics and healthcare providers.
By combining Cost Plus Drugs' model—which is based on transparency, efficiency and affordability—with Morris & Dickson's expertise and extensive distribution network, the partnership aims to:
- Mitigate drug shortages: Ensure a steady supply of hard-to-find injectable medications, particularly for acute care providers.
[Read more: GAO releases report on drug shortages]
- Democratize access: Improve essential medication affordability and accessibility to healthcare providers of all sizes.
- Enhance flexibility: Offer flexible sourcing freedom with no volume commitments.
- Streamline procurement: Provide a seamless ordering experience through the innovative Cost Plus Marketplace platform, powered by GraphiteRx.
Mark Cuban, co-founder of Mark Cuban Cost Plus Drug Company, said, "This partnership reshapes the supply chain for injectable medications. Together, we're not just filling gaps, we’re creating a more transparent, efficient, and patient-centered system."
[Read more: Ahold Delhaize USA inks agreement with Mark Cuban Cost Plus Drug Company]
"This collaboration goes beyond merely distributing medications. The innovation is about creating a new paradigm in health care that prioritizes transparency, affordability and accessibility. By bringing clarity to drug pricing and availability, passing significant cost savings directly to healthcare providers, and expanding reach to ensure medications are available when and where they're needed most, this partnership is set to transform lives," the company said.
Jody Hatcher, CEO of Morris & Dickson, said, "By joining forces with Mark Cuban Cost Plus Drug Company, we're setting a new standard for how critical medications are sourced reliably for patients. This is about more than distribution; it's about transforming lives and putting pharmacies and patients first."
"Beginning with injectable drugs, this collaboration lays the foundation for a comprehensive transformation of the pharmaceutical supply chain. As the partnership evolves, the focus will expand to address a wider range of medications and healthcare needs, ensuring that the platform meets the evolving needs of pharmacies," the Morris & Dickson said.
The company noted that a key advantage of the Cost Plus Marketplace is that pharmacies can join for free without purchase obligations or minimum order thresholds. This provides pharmacies with a valuable alternative source of supply, helping to mitigate risks associated with drug shortages and so much more, the company noted.